157 The mTOR kinase inhibitor AZD8055 induces cell death in Her2+ tumours partially or intrinsically resistant to ErbB2 inhibitors
Sarah V. Holt(Pharma Nord (United Kingdom)), Sylvie M. Guichard(Novo Nordisk (United Kingdom)), Edward M. Brown(Harvard University), Robert W. Wilkinson(Immunocore (United Kingdom)), Jonathan R. Dry(AstraZeneca (United Kingdom)), Gayle Marshall(Medicines Discovery Catapult), Zoë Howard(United States Department of Defense), Sarah E. Fenton, Armelle Logié(Sorbonne Université), Dominic I. James(AstraZeneca (United Kingdom))
Cited by 1
Related Papers
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
|Nature Genetics|2003|2k
Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
|Cell|1993|1.1k
Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation
|Nature Genetics|1994|599
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
|Nature Genetics|1995|593
Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression
|Journal of Cell Science|2004|344